Venus Concept Inc. (VERO) stock declined in the current market after the company announced that the FDA had granted clearance to market the Venus BlissMAX. VERO values at around $1.66, losing more than 7% from the previously closed value. At the end of the last trading session, the stock closed at $1.73. The stock traded volume in the previous trading session was around 173K shares.
Reason for the VERO stock decline
Venus Concept Inc. (VERO) announced that the FDA had granted clearance to market the Venus BlissMAX device in the United States. BlissMAX is a medical aesthetic platform that combines three technologies to reduce fat cellulite and strengthen muscles. For non-invasive abdominal and flank lipolysis in people with a BMI of 30 or less, BlissMAX utilizes innovative diode laser applicators. It also uses the (MP) 2 applicator for Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields with advanced VariPulseTM technology to reduce the appearance of cellulite. BlissMAX also includes the company’s FlexMAX EMS applicators, designed to condition and stimulate healthy muscles.
BlissMAX is significant to our body treatments because it combines three body treatment technologies in a single, cost-effective platform. The BlissMAX delivers exceptional results with minimal downtime and high profitability per procedure. Furthermore, the company anticipates a local commercial launch in the United States by the end of the first quarter of fiscal 2022. The company expects that the BlissMAX is the only device on the market that combines fat laser reduction, cellulite reduction, and muscle conditioning.
Effect on the stock
The stock of Venus Concept Inc. (VERO) is declining due to its BlissMax approved by the FDA. But is expected that it will increase the company’s revenue, ultimately increase its valuation. As a result, its company’s stock is expected to increase in the future. Investors are investing in its stock for higher capital gain in the future.
Conclusion
BlissMax is a new addition to its arsenal, and it will increase the company’s revenue. Venus Concept Inc. (VERO) is looking forward to spreading the product in the United States by the end of the first quarter of 2022.
